Related Experiment Videos
Efficient recombination-based methods for bacterial artificial chromosome fusion and mutagenesis
Bryce L Sopher1, Albert R La Spada
1Department of Laboratory Medicine, University of Washington Medical Center, Seattle, WA 98195, USA.
Gene
|February 21, 2006
Summary
Researchers developed new methods for manipulating bacterial artificial chromosomes (BACs) to study large genes in vivo. These techniques enable seamless gene editing and the creation of larger BAC constructs for advanced biological research and disease modeling.
Area of Science:
- Genomics
- Molecular Biology
- Biotechnology
Background:
- Advancements in genomic sequencing and bacterial artificial chromosome (BAC) libraries are transforming biological research.
- Studying large mammalian genes in vivo requires sophisticated tools for genetic manipulation.
Purpose of the Study:
- To develop novel methodologies for recombining bacterial artificial chromosomes (BACs) into larger constructs.
- To create a new method for introducing seamless mutations into BACs for in vivo studies.
Main Methods:
- A lambda bacteriophage-based method for recombining overlapping BACs using targeting constructs and recombination-based cloning.
- A "hybrid recombineering" method combining lambda bacteriophage and RecA systems for seamless gene targeting in BACs.
- Demonstrated methods by creating a 254 kb BAC for the human androgen receptor (hAR) gene and introducing a CAG repeat expansion.
Main Results:
- Successfully generated a 254 kb BAC containing the entire human androgen receptor (hAR) gene.
- Developed and applied a novel "hybrid recombineering" technique for precise BAC modification.
- Introduced a 162 CAG repeat expansion into the hAR BAC using the new method.
Conclusions:
- The developed BAC recombination and seamless mutation targeting methods facilitate in vivo study of large mammalian genes.
- Hybrid recombineering offers a powerful and efficient approach for BAC manipulation, analogous to yeast systems.
- These advancements enhance the utility of BACs for biological research and disease modeling.